Affirm Holdings enters September with a painful paradox: the stock is down 10% on the week and 6% on Tuesday alone, even as analysts queue up to raise price targets following a solid fiscal Q4 print.
The gap between analyst conviction and market action is the week's defining tension. In the two sessions after results landed on August 27, the Street responded emphatically. Goldman Sachs raised its target to $115, up from $106, maintaining Buy. Bernstein lifted to $110 from $100. Piper Sandler moved to $115 from $103. TD Cowen went to $124. Barclays, Cantor Fitzgerald, Susquehanna, and Oppenheimer all raised targets too — the entire post-earnings analyst wave moved in one direction. Scotiabank added fresh coverage Wednesday with a Sector Outperform and a $95 target. The consensus mean now stands at $99.23, roughly 42% above Tuesday's close of $69.94. That is an unusually wide gap, and it reflects a stock that has given back a meaningful chunk of its earnings-day gains. The stock gained about 1.7% the day results came out — a modest initial reaction — and has since sold off sharply, erasing that move and more.
Short interest tells a relatively calm story underneath the price action. Bears have been retreating for six consecutive weeks. SI has dropped from roughly 18 million shares in mid-July to 13.7 million now, sitting at 4.7% of free float — continuing the trend flagged in previous notes. The ORTEX short score has drifted lower still, from 40.8 two weeks ago to 39.5 today, consistent with ongoing short-side pressure coming off. Borrow conditions remain very loose: availability has actually expanded further this week, now at 1,696% relative to outstanding shorts, up from 1,491% last week. That means the lending pool holds roughly seventeen shares available for every one currently borrowed. Cost to borrow has dropped 35% on the week to just 0.31%. Nothing in the lending market signals a crowded or squeezed short book.
Options positioning has moderated from the defensive extreme seen heading into earnings but remains slightly put-heavy. The put/call ratio is 1.12, just above its 20-day average of 1.10 and only half a standard deviation above the mean — well below the two-standard-deviation spike seen pre-results. The 52-week high is 1.23 and the low is 0.81, so the current reading sits in the upper half of the year's range without screaming alarm. Options traders hedged aggressively into the print and have not yet fully unwound that caution, even though the earnings outcome was benign.
The fundamental picture the Street is pricing reflects genuine momentum. Affirm ranks in the 97th and 98th percentiles on 30-day and 90-day EPS momentum respectively, and the 98th percentile on EPS surprise — meaning the company has been beating estimates as consistently as almost anyone in the universe. Bulls point to BNPL leadership, the potential transformative impact of a bank charter on funding costs, and international expansion. Bears note macro sensitivity to consumer spending, US revenue concentration, and a valuation that — even after this week's decline — carries a P/E near 16x trailing and an EV/EBITDA approaching 18x on a business that is still building toward scale. The forward EPS growth score ranks only in the 11th percentile, a reminder that consensus pencils in limited near-term earnings expansion despite strong momentum on beats.
On the ownership side, JP Morgan Asset Management added nearly 10 million shares in the most recent quarter — one of the larger institutional moves in the register. Capital Research remains the biggest institutional holder at 14.6% of shares. Founder and CEO Max Levchin holds 8.1%. The COO's August 28 sale of $7.1 million in shares was executed entirely under a pre-arranged 10b5-1 plan — a scheduled disposal rather than a discretionary signal — and should be read accordingly.
The question heading into the next few weeks is whether the gap between the $99 analyst consensus and the $70 stock price narrows from the top down or the bottom up — and what it takes to close it.
See the live data behind this article on ORTEX.
Open AFRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
